Local induction of a specific Th1 immune response by allergen linked immunostimulatory DNA in the nasal explants of ragweed-allergic subjects

Allergology International

Volumn 58, Issue 4, 2009, Pages 565-572

  Tulic, Meri K ^a   Christodoulopoulos, Pota ^b   Fiset, Pierre Olivier ^b   Vaillancourt, Patrice ^b   Lavigne, Francois ^c   Marshall, Jason D ^d   Van Nest, Gary ^d   Eiden, Joseph J ^d   Hamid, Qutayba ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b MCGILL UNIVERSITY   (Canada)

^c NOTRE DAME HOSPITAL   (Canada)

^d Dynavax Technologies Corporation   (United States)

Author keywords

Allergen; Allergic rhinitis; Cpg motif; Immunotherapy; Vaccination

Indexed keywords

CYTOKINE; DNA; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; RAGWEED ANTIGEN; TETANUS TOXOID; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC RHINITIS; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; IMMUNOSTIMULATION; IMMUNOTHERAPY; IN SITU HYBRIDIZATION; NEUTROPHIL; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; RAGWEED POLLEN; T LYMPHOCYTE; TH1 CELL;

EID: 75449087228     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.09-OA-0108     Document Type: Article

References (19)

1. Bousquet J, Lockey R, Malling HJ et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998;1:401-5.
2. Creticos PS. Immunotherapy with allergens. JAMA 1992; 268:2834-9.
3. Marsh DG, Lichtenstein LM, Campbell DH. Studies on "allergoids" prepared from naturally occurring allergens. I. Assay of allergenicity and antigenicity of formalinized rye group I component. Immunology 1970;18:705-22.
4. Lee WY, Sehon AH. Abrogation of reaginic antibodies with modified allergens. Nature 1977;267:618-9.
5. Roman M, Martin-Orozco E, Goodman JS et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 1997;3:849-54.
6. Tighe H, Takabayashi K, Schwartz D et al. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000;106:124-34.
7. Broide D, Schwarze J, Tighe H et al. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J Immunol 1998; 161:7054-62.
8. Durham SR, Till SJ. Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998;102:157-64.
9. Marshall JD, Abtahi S, Eiden JJ et al. Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy. J Allergy Clin Immunol 2001;108:191-7.
10. Simons FE, Shikishima Y, Van Nest G, Eiden JJ, Hay-Glass KT. Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. J Allergy Clin Immunol 2004;113: 1144-51.
11. Tulic MK, Fiset PO, Christodoulopoulos P et al. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J Allergy Clin Immunol 2004;113:235- 41.
12. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993;8:35-42.
13. Hamid Q, Wharton J, Terenghi G et al. Localization of atrial natriuretic peptide mRNA and immunoreactivity in the rat heart and human atrial appendage. Proc Natl Acad Sci U S A 1987;84:6760-4.
14. Ying S, Durham SR, Barkans J et al. T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol 1993;9:356-60.
15. Akdis M. Immunologic responses to sublingual allergen immunotherapy. Clin Allergy Immunol 2008;21:71-86.
16. Asai K, Foley SC, Sumi Y et al. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy increases CD4+CD25+ T cells in the nasal mucosa of subjects with allergic rhinitis. Allergol Int 2008;57:377-81.
17. Wild JS, Sur S. CpG oligonucleotide modulation of allergic inflammation. Allergy 2001;56:365-76.
18. Takeshita F, Leifer CA, Gursel I et al. Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 2001;167:3555-8.
19. Krieg AM. The role of CpG motifs in innate immunity. Curr Opin Immunol 2000;12:35-43.